AI Chip Valuations, Pharma Biosimilars & Corporate Pivots
Analysis of recent market shifts including Cerebras' IPO surge, Cisco and Ford's strategic AI investments, Sandoz's biosimilar expansion, and activist pressure on Markel Group's conglomerate model.